Capecitabine in Low Risk Triple Negative Breast Cancer
Clinical trial NCT06787339 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT06787339
- Sponsor
- Fudan University
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2025-01-15
- Primary completion
- 2028-12-31
- Enrollment
- 198
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.